Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Thromb Haemost. 2018 Jan 30;16(3):500–507. doi: 10.1111/jth.13937

Table 1.

Demographics of Analyzed Patients by PE* Risk Category.

Low-Risk PE

46 patients
Intermediate/
High-Risk PE
46 patients
Intermediate-
Risk PE
28 patients
High-Risk PE

18 patients
Age (mean, SD) 62 15 62 16 61 18 64 12
n % n % n % n %
Female 20 43% 20 43% 13 46% 7 39%
Race:
  White 43 94% 41 89% 25 89% 16 89%
  Black 2 4% 5 11% 3 11% 2 11%
  Other 1 2% 0 0% 0 0% 0 0%
Ethnicity:
  Non-Hispanic 45 98% 46 100% 28 100% 18 100%
  Hispanic 1 2% 0 0% 0 0% 0% 0%
Insurance:
  Private 27 59% 32 70% 20 72% 12 67%
  Medicare 17 37% 11 24% 6 21% 5 28%
  Other 2 4% 3 6% 2 7% 1 5%
Comorbidities:
  Coronary Artery Disease 6 13% 3 6% 3 11% 0 0%
  Congestive Heart Failure 3 6% 4 9% 1 4% 3 17%
  Lung Disease § 10 22% 10 22% 6 21% 4 22%
    Asthma 5 11% 4 9% 2 7% 2 11%
    COPD 3 6% 2 4% 1 4% 1 6%
    Other 2 4% 5 11% 5 18% 0 0%
   Malignancy 19 41% 20 43% 9 32% 11 61%
    Active/Palliative 8 17% 8 17% 1 4% 7 39%
    Inactive 10 22% 12 26% 8 29% 4 22%
    Status Unknown 1 2% 0 0% 0 0% 0 0%
Renal Insufficiency or Failure** 1 2% 2 4% 2 7% 0 0%
Cerebrovascular Disease†† 4 9% 4 9% 3 11% 1 6%

Table 1 Notes:

*

PE = Pulmonary Embolism;

SD = Standard Deviation;

COPD = Coronary Artery Disease includes any history of myocardial infarction, angina, coronary artery stenting or bypass surgery

§

Asthma, COPD and Other lung disease are not mutually exclusive.

Active malignancy includes any cancer that is being actively treated or palliated, and metastatic disease. Inactive cancer includes a prior history of cancer that is not actively being treated or palliated.

**

Renal insufficiency or failure includes renal insufficiency, renal failure and hemodialysis.

††

Cerebrovascular disease includes any history of ischemic or hemorrhagic stroke or transient ischemic attack.